Investors

Mauna Kea Technologies
Stock Information

Mauna Kea Technologies
Stock Information

Stay up to date on all our investor news

0,1076€

Last updated
20/10/2026 - 23:00

'

-3,24%

Events and
Presentations

Financial
Results

Governance

News

Mauna Kea Technologies Reports Nine-Month 2026 Sales of €4.4 Million, Up 24% at Constant Exchange Rates 

Mauna Kea Technologies Reports Nine-Month 2026 Sales of €4.4 Million, Up 24% at Constant Exchange Rates 

Mauna Kea Technologies Announces 2026 Half-Year Results

Mauna Kea Technologies Announces 2026 Half-Year Results

Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer 

Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer 

No results found.

Shareholding Structure

Stock Information

IDENTIFICATION CODES

ISIN : FR0010609263

Ticker : ALMKT

ANALYST COVERAGE

ALLINVEST SECURITIES

EUROLAND CORPORATE
EUROLAND CORPORATE

Raphaël Génin

STATUTORY AUDITORS

• EY and Others, represented by Mr Franck SEBAG, 1-2 place des Saisons, 92400 Courbevoie- Paris La Défense, France

ANALYST REPORTS

View here